What PHARMABRAND S.A. does

PHARMABRAND S.A. is an Ecuadorian pharmaceutical company founded in 2000 through the acquisition of the Schering Plough Ecuador plant. It manufactures and commercializes branded pharmaceutical products across two main lines: 'Línea Pharma' (59 prescription medications spanning cardiovascular, pain, general medicine, pediatric, osteo/metabolic, and ophthalmic therapeutic categories) and 'Línea OTC' (14 over-the-counter products including nutritional supplements, sweeteners, and analgesics), totaling 73 SKUs. The company maintains FDA, ISO 9001-2008, and GMP certifications and holds granted patents in Ecuador, the United States, and the European Community for proprietary compositions in anti-inflammatory, immunostimulant, and skin-regeneration categories, including formulations leveraging native Ecuadorian Sierra and Amazonian plants.

The business operates on a sales-led GTM model combining wholesale pharmacy distribution across Ecuador with direct engagement of healthcare professionals through a medical-code-gated portal and Vademecum database. The company runs international export operations to the United States, Chile, and Bolivia, and has stated plans to expand into Mexico, Peru, and Colombia. Manufacturing is handled in part through wholly owned subsidiary FARMACID S.A., which operates a dedicated processing plant. Revenue derives from one-time sales of branded prescription and OTC products; no subscription or licensing model is disclosed, and pricing is not publicly itemized.

Capital structure reflects active use of Ecuadorian debt markets: a 2018 USD 5M bond (AA rated), a 2023 USD 4M second bond, and a 2023 USD 2M commercial paper program, culminating in an AAA rating from GLOBALRATINGS CALIFICADORA DE RIESGOS S.A. for both 2025 and 2026 based on audited 2021-2024 financials. The firm is privately held with no disclosed parent, no public ticker, and no individual shareholder structure available in source materials. Operations are concentrated in Quito (headquarters, multiple offices, and subsidiary manufacturing) and Guayaquil (regional HQ), with 127 employees total.

Name

PHARMABRAND S.A.

Legal name

PharmaBrand S.A.

Website

https://pharmabrand.com.ec

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

101–250 employees

Short description

PHARMABRAND S.A. is a privately held Ecuadorian pharmaceutical manufacturer founded in 2000, producing 73 branded prescription and OTC products across six therapeutic categories, exporting to the USA, Chile, and Bolivia, and holding international FDA, ISO, and GMP certifications plus US and EU patents.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE)

Keywords

• Pharmaceutical manufacturing
• Prescription medications
• Over-the-counter products
• Generic pharmaceuticals
• Drug formulations

Headquarters

HQ city

Quito

HQ country

Ecuador

HQ region

Latin America

Offices5 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Pharmaceutical Products Manufacturing and Sales: Manufacturing and commercialization of branded pharmaceutical products including prescription medications and OTC products across multiple therapeutic categories including cardiovascular, pain, general medicine, pediatrics, metabolic, and ophthalmic treatments. Products sold through pharmacies and healthcare institutions domestically and internationally.
2. International Export: Export of pharmaceutical products to international markets including USA, Chile, and Bolivia. Company has expansion plans for Mexico, Peru, and Colombia.
3. Subsidiary Operations through FARMACID SA: Through subsidiary FARMACID SA, operates additional processing plant for drug manufacturing

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

PharmaBrand S.A. is an Ecuadorian pharmaceutical laboratory that manufactures and commercializes a portfolio of 73 branded pharmaceutical products, comprising 59 prescription medications (Línea Pharma) and 14 over-the-counter products (Línea OTC). The prescription line spans cardiovascular, pain, general medicine, pediatric, osteo-metabolic, and ophthalmic therapeutic categories, while the OTC line covers nutritional supplements, sweeteners, analgesics, and mineral supplements. The company operates its own manufacturing through subsidiary FARMACID S.A. and conducts in-house R&D into novel dosage forms, leveraging Ecuadorian natural resources with international patents granted in the USA and European Community.

Product overview

PharmaBrand S.A. is an Ecuadorian pharmaceutical company that manufactures and distributes prescription medications and over-the-counter (OTC) products. The company operates two main product lines: 'Línea Pharma' (prescription medications) and 'Línea OTC' (over-the-counter products). The Línea Pharma portfolio covers six therapeutic categories: Cardiovascular (Dueto, Arados, Cardiol, Vasodil, Antiplac, Lipobrand, Zetina), Pain Management (Artrox, Luvit, Flexidol, Aproxen, Demexan, Flenac, Prednisona, Alivol), General Medicine (Omecidol, Septin, Flucocid, Andiar, Bitrim, Helicopack, Herpexil, Amebizol, Zicon, Nokar, Rinex), Pediatric (Feveril, Mucocid, Parasipack, Fagol, Fasdal), Osteo/Metabolic (Rubir, Osteoplus, Osteoplus D, Orlifit, Glucocid, Simarín Q, Simarín Q Forte), and Ophthalmic (Tobral, Tobral D, Luvis, Viclar, Gentabrand, Gentabrand D). The OTC line includes nutritional supplements (Orange C, Recorderis, Simarín Plus), sweeteners (Dieta Sweet with aspartame, Stevia Sweet with stevioside), analgesics (Apirec Plus), and mineral supplements (Calcid, Calcid D). The company holds ISO 9001-2008, FDA, and GMP certifications and has received international patents for selected products in the US and European Community.

Differentiator

Problem solved

Functional benefit

Brands

• FARMACID: Pharmaceutical processing plant operated by PharmaBrand's subsidiary, FARMACID S.A.

Products and services

• Línea Pharma Cardiovascular Prescription cardiovascular medications for hypertension, lipid management, and cardiac conditions, including Dueto (Losartan + Amlodipine), Arados, Arados HCT, Zetina, Cardiol, Vasodil, Antiplac, and Lipobrand.
• Línea Pharma Dolor (Pain Management) Prescription pain management medications for musculoskeletal pain and inflammation, including Artrox (meloxicam, the company's first patented product), Luvit, Flexidol, Alivol, Aproxen, Demexan, Flenac (diclofenac sodium), and Prednisona.
• Línea Pharma General Medicine Prescription general medications for gastrointestinal, anti-infective, and respiratory conditions, including Omecidol (omeprazole), Septin, Flucocid (fluconazole), Andiar (montelukast), Bitrim, Helicopack, Herpexil (acyclovir), Amebizol, Zicon, Nokar, and Rinex.
• Línea Pharma Pediátrica (Pediatric) Pediatric prescription medications for respiratory, parasitic, and general conditions, including Feveril, Rinex, Mucocid (ambroxol), Parasipack, Fagol (albendazole), and Fasdal.
• Línea Pharma Osteo/Metabólica Prescription medications for osteoporosis, diabetes, and metabolic disorders, including Rubir (ibandronic acid), Osteoplus D, Osteoplus (alendronate), Orlifit (orlistat), Glucocid (metformin), Simarín Q, and Simarín Q Forte.
• Línea Pharma Oftálmica (Ophthalmic) Prescription ophthalmic medications for eye infections and inflammation, including Tobral, Tobral D (tobramycin/dexamethasone), Luvis, Viclar, Gentabrand, and Gentabrand D.
• Línea OTC (Over-the-Counter) Over-the-counter products for nutritional supplementation and minor ailment relief, including Orange C (vitamin C), Recorderis (multivitamin with ginseng), Simarín Plus (hepatoprotective), Dieta Sweet (aspartame sweetener), Apirec Plus (analgesic), Calcid, Calcid D (calcium supplements), No grip, Antacid, and Stevia Sweet (stevia sweetener).
• Apirec Plus OTC analgesic combining 500mg paracetamol and 50mg caffeine for headache relief, mild-to-moderate pain, migraine, and tension headache. Available in 30-tablet coated tablet presentation.
• Dieta Sweet Zero-calorie artificial sweetener containing 36mg aspartame, 200 times sweeter than sucrose. Safe for diabetics, does not cause dental caries, and has no teratogenic or carcinogenic effects. Certified ISO and GMP.
• Calcid D Calcium supplement with 500mg elemental calcium and 200 IU vitamin D3 per tablet, indicated for calcium and vitamin D deficiency, osteoporosis prevention and treatment. Available in 30-tablet bottles.
• Orange C Vitamin C supplement containing 1g ascorbic acid per sachet for prevention and treatment of vitamin C deficiency and increased requirements during growth, pregnancy, lactation, and infectious diseases.
• Recorderis Multivitamin with minerals and ginseng containing vitamins A, B-complex, C, D3, E, plus minerals including calcium, magnesium, zinc, and selenium. For prevention of vitamin/mineral deficiencies during convalescence and inadequate diets.
• Simarín Plus Hepatoprotective supplement combining 140mg silymarin with B-complex vitamins. Indicated for toxic-metabolic liver conditions, alcoholic hepatitis, and liver cirrhosis. Available in 10 and 40-capsule boxes.
• Stevia Sweet Natural sweetener containing 20mg stevioside, 200-300 times sweeter than sucrose, calorie-free, water-soluble crystalline powder from Stevia rebaudiana plant. Available in 1g sachets in boxes of 5-500 units.

Quantifiable outcome

• AAA credit rating from GLOBALRATINGS

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Seven partnerships are on record, tiered minor and core.

• Escuelas Estatales (State Schools)minorStrategic or Co-development PartnerPharmaBrand participates in Regalando Sonrisas campaign in Zumbahua through cooperation agreements with state schools for social responsibility initiatives addressing vulnerable populations
• Misión SalesianaminorStrategic or Co-development PartnerCivil society partner in Regalando Sonrisas campaign implementing social responsibility projects for vulnerable populations in Zumbahua
• Voluntarios italianos de la operación Mato GrossominorStrategic or Co-development PartnerInternational volunteers participating in Regalando Sonrisas campaign for social responsibility initiatives
• Corporate Volunteers (Pharmabrand)minorStrategic or Co-development PartnerPharmabrand corporate volunteering program integrated with social responsibility campaign Regalando Sonrisas
• FARMACID SAcoreTechnology or IntegrationSubsidiary company with pharmaceutical processing plant in Ecuador, operating as related manufacturing facility for PharmaBrand products with first class technology
• Red de Empresas por la Erradicación del Trabajo Infantil y PETIminorStrategic or Co-development PartnerPharmaBrand is part of the business network for child labor eradication, working on creation of employment opportunities and youth employability
• Mujeres Emprendedoras ProgramminorStrategic or Co-development PartnerProgram for employee families to expand business opportunities, stimulate economy and improve income management

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Genomma Lab: Genomma Lab is a Mexican-based, Latin-American-focused pharmaceutical and OTC company with a similar portfolio of branded generics and OTC products. Comparable to PHARMABRAND in its regional emerging-market focus and portfolio breadth across therapeutic categories.
• Laboratorios Genfar: Genfar is a Sanofi-owned generic pharmaceutical company operating across Ecuador, Colombia, and other Latin American markets. Directly comparable to PHARMABRAND in the generic and OTC pharmaceutical categories across overlapping LatAm geographies with similar competitive dynamics.
• Eurofarma: Eurofarma is a Brazilian multinational pharmaceutical company with a portfolio of branded generics, prescription, and OTC products across Latin America. Comparable to PHARMABRAND in its Latin American emerging-market focus and broad therapeutic coverage.
• Mack Laboratorios: Mack Laboratorios is an Ecuadorian pharmaceutical manufacturer with branded prescription and OTC offerings across therapeutic categories. Directly comparable to PHARMABRAND in domestic Ecuadorian market positioning and product breadth.

Broad incumbents

• Pfizer: Pfizer is a global pharmaceutical incumbent with branded prescription products across multiple therapeutic areas including cardiovascular and pain. Comparable to PHARMABRAND as a broad-incumbent competitor in the same therapeutic categories.
• Teva Pharmaceutical Industries: Teva is the world's largest generic pharmaceutical manufacturer with significant global presence and expertise in cost-competitive generic drug production. Comparable to PHARMABRAND as a broad-incumbent generic pharmaceutical competitor in the same molecule categories.
• Bayer: Bayer is a global pharmaceutical conglomerate with prescription and OTC products across cardiovascular, pain, and other therapeutic categories. Comparable to PHARMABRAND as a broad-incumbent competitor in overlapping therapeutic areas, particularly in Latin America.

Emerging players

• Roemmers: Laboratorios Roemmers is an Argentine pharmaceutical company with branded prescription and OTC products across cardiovascular, pain, and multiple other therapeutic areas. Comparable to PHARMABRAND in emerging-market pharmaceutical manufacturer profile and therapeutic breadth.
• Megalabs: Megalabs is a Latin American pharmaceutical company with prescription and OTC products across multiple countries. Comparable to PHARMABRAND in its emerging-market regional focus and portfolio diversification strategy.
• Laboratorios Bago: Laboratorios Bago is an Argentine pharmaceutical company with branded prescription and OTC products across multiple therapeutic categories. Comparable to PHARMABRAND in Latin American emerging-market pharmaceutical manufacturer profile.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/pharmabrand-s-a

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PHARMABRAND S.A.